Literature DB >> 2498217

Epidemiological model and cost-effectiveness analysis of tuberculosis treatment programmes in Indonesia.

M R Joesoef1, P L Remington, P T Jiptoherijanto.   

Abstract

An epidemiological model of tuberculosis, based on the natural history of tuberculosis and the control programmes in Indonesia, was constructed. This model was used for estimating future tuberculosis-prevented cases and costs for three treatment strategies--the 100% standard course, the 100% short course, and the existing strategy (a combination of 65% standard course and 35% short course)--in accordance with the master plan of the Indonesian Government's tuberculosis control programme. A cost-effectiveness analysis of the three strategies confirmed that the short-course strategy was the most cost-effective. Sensitivity analysis, which applied a broad range of parameters, continued to confirm the short-course strategy as the most cost-effective. If the short-course strategy had been applied in 1980 instead of the existing strategy (using the most likely parameters), the short-course strategy would prevent 1.8 million sputum-positive cases and would save 61.0 million dollars by the year 2000.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498217     DOI: 10.1093/ije/18.1.174

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  6 in total

Review 1.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

2.  Indices of therapeutic outcome in pharmacoeconomic evaluation of drug therapy.

Authors:  S F Hurley
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

3.  Defining criteria for the pharmacoeconomic evaluation of new oral cephalosporins.

Authors:  P G Davey; M Malek
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

Review 4.  Cost effectiveness of antituberculosis interventions.

Authors:  A Castelo; P A Mathiasi; R Iunes; A L Kritski; M Dalcolmo; F Fiuza de Melo; M Drummond
Journal:  Pharmacoeconomics       Date:  1995-11       Impact factor: 4.981

5.  Preventive strategy and general practice.

Authors:  G Rose
Journal:  Br J Gen Pract       Date:  1993-04       Impact factor: 5.386

6.  Heightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TB.

Authors:  Jason D Bishai; William R Bishai; David M Bishai
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.